Literature DB >> 20218482

Field evaluation of a malaria rapid diagnostic test (ICT Pf).

Devanand Moonasar1, Ameena E Goga, Philip S Kruger, Christine La Cock, Rajendra Maharaj, John Frean, Daniel Chandramohan.   

Abstract

BACKGROUND: Malaria rapid diagnostic tests (MRDTs) are quick and easy to perform and useful for diagnosing malaria in primary health care settings. In South Africa most malaria infections are due to Plasmodium falciparurrm, and HRPII-based MRDTs have been used since 2001. Previous studies in Africa showed variability in sensitivity and specificity of HRPII-based MRDTs; hence, we conducted a field evaluation in Limpopo province to determine the accuracy of the MRDT currently used in public sector clinics and hospitals.
METHODS: A cross-sectional observational study was conducted to determine the sensitivity and specificity of an ICT Pf MRDT. We tested 405 patients with fever with ICT Pf MRDT and compared the results with blood film microscopy (the gold standard). RESULTS. The overall sensitivity of the ICT Pf MRDT was 99.48% (95% confidence interval (CI) 96.17-100%), while specificity was 96.26% (95% CI 94.7-100%). The positive predictive value of the test was 98.48 (99% CI 98.41-100%), and the negative predictive value was 99.52% (95% CI 96.47-100%).
CONCLUSIONS: The ICT Pf MRDT is an appropriate test to use in the field in South Africa where laboratory facilities are not available. It has a high degree of sensitivity and acceptable level of specificity in accordance with the World Health Organization criteria. However, sensitivity of MRDT at low levels of parasitaemia (<100 parasites/microl of blood) in field conditions must still be established.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 20218482

Source DB:  PubMed          Journal:  S Afr Med J


  7 in total

Review 1.  Rapid diagnostic tests for diagnosing uncomplicated P. falciparum malaria in endemic countries.

Authors:  Katharine Abba; Jonathan J Deeks; Piero Olliaro; Cho-Min Naing; Sally M Jackson; Yemisi Takwoingi; Sarah Donegan; Paul Garner
Journal:  Cochrane Database Syst Rev       Date:  2011-07-06

Review 2.  Rapid diagnostic tests for diagnosing uncomplicated non-falciparum or Plasmodium vivax malaria in endemic countries.

Authors:  Katharine Abba; Amanda J Kirkham; Piero L Olliaro; Jonathan J Deeks; Sarah Donegan; Paul Garner; Yemisi Takwoingi
Journal:  Cochrane Database Syst Rev       Date:  2014-12-18

3.  Malaria rapid diagnostic kits: quality of packaging, design and labelling of boxes and components and readability and accuracy of information inserts.

Authors:  Philippe Gillet; Jessica Maltha; Veerle Hermans; Raffaella Ravinetto; Cathrien Bruggeman; Jan Jacobs
Journal:  Malar J       Date:  2011-02-13       Impact factor: 2.979

4.  Accuracy of rapid tests for malaria and treatment outcomes for malaria and non-malaria cases among under-five children in rural Ghana.

Authors:  Frank Baiden; Jayne Webster; Mathilda Tivura; Rupert Delimini; Yvonne Berko; Seeba Amenga-Etego; Akua Agyeman-Budu; Akosua B Karikari; Jane Bruce; Seth Owusu-Agyei; Daniel Chandramohan
Journal:  PLoS One       Date:  2012-04-13       Impact factor: 3.240

5.  Comparison of a PfHRP2-based rapid diagnostic test and PCR for malaria in a low prevalence setting in rural southern Zambia: implications for elimination.

Authors:  Natasha M Laban; Tamaki Kobayashi; Harry Hamapumbu; David Sullivan; Sungano Mharakurwa; Philip E Thuma; Clive J Shiff; William J Moss
Journal:  Malar J       Date:  2015-01-28       Impact factor: 2.979

6.  Adherence to Hand Hygiene among Nurses and Clinicians at Chiradzulu District Hospital, Southern Malawi.

Authors:  Monica Nzanga; Mindy Panulo; Tracy Morse; Kondwani Chidziwisano
Journal:  Int J Environ Res Public Health       Date:  2022-09-02       Impact factor: 4.614

7.  Bayesian Latent Class Models in malaria diagnosis.

Authors:  Luzia Gonçalves; Ana Subtil; M Rosário de Oliveira; Virgílio do Rosário; Pei-Wen Lee; Men-Fang Shaio
Journal:  PLoS One       Date:  2012-07-23       Impact factor: 3.240

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.